BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
Emory University established the Tobacco Technical Assistance Consortium
On Feb. 11, 2002, three leading national health organizations announced they had committed $15 million to establish the…
The Translational Genomics Research Institute (TGen) was envisioned
On Feb. 7, 2002, an assembly of more than fifty leaders and visionaries in science, medicine, government and…
FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
Cook County Hospital opened doors to John Stroger Hospital of Cook County
In February 2002, the doors opened to the John Stroger Hospital of Cook County, a new state-of-the-art, 464-bed,…
Andrew C von Eschenbach became the twelfth director of the National Cancer Institute, serving until 2006
On Jan. 22, 2002, Dr. Andrew C. von Eschenbach became the twelfth director of the National Cancer Institute…
ZymoGenetics announced its Initial Public Offering
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
Los Angeles Cancer Center Received $15 Million for Woman’s Health Center
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
Diagnostics | FDA | Medicine | Pharmaceutical | Therapeutics
The Best Pharmaceuticals for Children Act improved safety and efficacy of patented and off-patent medicines for children
In 2002, the U.S. Congress passed the Best Pharmaceuticals for Children Act that improved safety and efficacy of…
Digital diagnostic technology developed with creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
Red River Valley Research Corridor was established
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
The Nevada Cancer Institute was founded
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
The Cancer Center at Baylor College of Medicine was established
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
Virginia Commonwealth University and INOVA Fairfax partnered to establish medical program in Northern Virginia
In 2002, the Virginia Commonwealth University (VCU) and INOVA Fairfax partnered to establish a medical program in Northern…
Gateway Building opened at Virginia Commonwealth University Medical Center
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
Siemens launched Triano, the first hearing instrument with three microphones
In 2002, Siemens, now Sivantos, launched Triano, the first hearing instrument with three microphones. This new hearing system…
Biotechnology | FDA | Medicine | Therapeutics
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
Stanford researchers identified a novel gene family involved in asthma
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
$2.5 million award from Jeld-Wen Foundation endowed OHSU Chair in Leukemia Research for Brian Druker
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
Dr. Leland Hartwell was awarded the 2001 Nobel Prize for Medicine ‘for discoveries of key regulators of the cell cycle’
On Oct. 8, 2001, Dr. Leland ‘Lee’ Hartwell from Fred Hutchinson Cancer Research Center was awarded the Nobel…
Biotechnology | Disease | FDA | Therapeutics
Genentech drug Cathflo Activase (alteplase) was approved
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The National Cancer Institute launched the Consumer Advocates in Research and Related Activities program
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
The Alvin J Siteman Cancer Center was named a NCI Designated Cancer Center
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
The Hutchinson Cancer Research Center played key role in largest-ever prostate-cancer prevention study
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
Oregon Health & Science University merged with Oregon Graduate Institute of Science and Technology
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
Louis Stokes Laboratories was dedicated
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
The FDA approved Gleevec, developed by OHSU, for treatment of chronic myeloid leukemia
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…